Li XF - Search Results

1

[Effect of Body Mass Index on the Prognosis of Mantle Cell Lymphoma].

Zhang SX, Xie YH, Weng P, Xu SJ, Tian HY, Guo JR, Liu TB, Shen JZ, Li XF. Zhang SX, et al. Among authors: li xf. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Dec;30(6):1757-1765. doi: 10.19746/j.cnki.issn.1009-2137.2022.06.020. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36476900 Chinese.

2

[Expression of Hydrodynamic Injection-mediated PD-L1 in Myeloablative Conditioning Mouse Model].

Li XF, Li NN, Yang FE, Chen YZ. Li XF, et al. Among authors: li nn. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Oct;23(5):1432-7. doi: 10.7534/j.issn.1009-2137.2015.05.040. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015. PMID: 26524052 Chinese.

3

A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.

Gu ZY, Dong YJ, Fu XR, Li NN, Liu Y, Wu XX, Wang YN, Li YH, Ren HY, Zhang MZ, Li XF, Wang MH, Wu YM, Liu DH, Wang Z, Hu LD, Huang WR. Gu ZY, et al. Among authors: li yh, li nn, li xf. Chin Med J (Engl). 2021 Jun 16;134(13):1584-1592. doi: 10.1097/CM9.0000000000001575. Chin Med J (Engl). 2021. PMID: 34133361 Free PMC article.

4

Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.

Li H, Li X, Chen Y, Li D, Chen X, Zhu Z, Wang Y, Huang J, Chen P, Chen Y, Li N. Li H, et al. Front Immunol. 2021 Nov 4;12:733326. doi: 10.3389/fimmu.2021.733326. eCollection 2021. Front Immunol. 2021. PMID: 34804017 Free PMC article. Clinical Trial.

5

Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma.

Zhu Z, Li X, Yuan X, Chen X, Lin T, Guo X, Li N. Zhu Z, et al. Front Immunol. 2024 Jul 18;15:1439253. doi: 10.3389/fimmu.2024.1439253. eCollection 2024. Front Immunol. 2024. PMID: 39091501 Free PMC article.

6

[Establishment of a graft-versus-host disease mouse model for haplo-identical bone marrow transplantation with busulfan and fludarabine conditioning regimen].

Li N, Hu W, Li X, Yang W, Chen P, Chen Y. Li N, et al. Zhonghua Xue Ye Xue Za Zhi. 2015 Mar;36(3):238-40. doi: 10.3760/cma.j.issn.0253-2727.2015.03.014. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 25854470 Free PMC article. Chinese. No abstract available.

7

Li D, Li X, Liao L, Li N. Li D, et al. Am J Blood Res. 2020 Feb 15;10(1):1-10. eCollection 2020. Am J Blood Res. 2020. PMID: 32206440 Free PMC article. Review.

8

Pazopanib in patients with metastatic renal cell carcinoma: a single-center, real-world, retrospective Chinese study.

Chen J, Ye W, Jiang W, Li X, Liu R, Lin B, Xiang J, Tian W, Bai J, Zuo T, Lin B, Guo Y, Zheng S. Chen J, et al. Transl Androl Urol. 2021 Mar;10(3):1321-1331. doi: 10.21037/tau-21-111. Transl Androl Urol. 2021. PMID: 33850766 Free PMC article.

9

High Efficacy of Stem Cell Mobilization With Etoposide+Cytarabine Plus G-CSF in Patients With Multiple Myeloma.

Zhu Z, Li X, Liu Y, Chen P, Chen X, Li H, Huang J, Chen Y, Li N. Zhu Z, et al. Front Oncol. 2022 Jan 27;12:825550. doi: 10.3389/fonc.2022.825550. eCollection 2022. Front Oncol. 2022. PMID: 35155259 Free PMC article.

10

Real-world data on the efficacy and safety of pazopanib in IMDC favorable- and intermediate-risk metastatic renal cell carcinoma: a multicenter retrospective cohort study of Chinese patients.

Anwaier A, Chen J, Zhou H, Zhao X, Zheng S, Li X, Qu Y, Shi G, Zhang H, Wu J, Ye D. Anwaier A, et al. Transl Androl Urol. 2022 May;11(5):694-709. doi: 10.21037/tau-22-312. Transl Androl Urol. 2022. PMID: 35693709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,202 results

Search Page

Filters